Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Biomarin Pharmaceuticals
(NQ:
BMRN
)
78.06
USD
+0.95 (+1.23%)
Streaming Delayed Price
Updated: 10:05 AM EDT, Apr 13, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
70,312
Open
77.44
Bid (Size)
78.00 (1)
Ask (Size)
78.13 (2)
Prev. Close
77.11
Today's Range
76.86 - 78.29
52wk Range
71.35 - 131.94
Shares Outstanding
176,713,314
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
BioMarin to Host First Quarter 2021 Financial Results Conference Call and Webcast on Thursday, April 29 at 4:30pm ET
Today 8:30 EDT
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, April 29,...
From
PR Newswire
BioMarin Announces Oral Presentation at ENDO2021, the Endocrine Society's Annual Meeting, with Data Demonstrating 2 Years of Treatment Benefit in Children with Achondroplasia Treated with Vosoritide
March 20, 2021
Height Gain is Maintained in 2nd Year of Treatment
From
PR Newswire
Performance
YTD
-9.55%
-9.55%
1 Month
-0.42%
-0.42%
3 Month
-3.91%
-3.91%
6 Month
-2.24%
-2.24%
1 Year
-5.94%
-5.94%
More News
Read More
BioMarin Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A
March 08, 2021
From
PR Newswire
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
March 03, 2021
From
PR Newswire
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates
February 25, 2021
From
PR Newswire
BioMarin to Participate in Four Upcoming Virtual Investor Conferences
February 24, 2021
From
PR Newswire
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors
February 18, 2021
From
PR Newswire
BioMarin Pharmaceutical Moves Up In Market Cap Rank, Passing Howmet Aerospace
April 12, 2021
Tags
Stocks
From
Market News Video
Noteworthy Wednesday Option Activity: BMRN, PLCE, KEX
April 07, 2021
Tags
Stocks
From
Market News Video
PBE's Holdings Could Mean 19% Gain Potential
April 01, 2021
Tags
ETFs
From
ETF Channel
7 Pharmaceutical Stocks Working on Their Next Blockbuster
March 12, 2021
Tags
ARGX
BMRN
NASDAQ:MRTX,NYSE:NVS,NYSE:BHVN,NASDAQ:BMRN,NYSE:NVO,OTCMKTS:DSNKY,NASDAQ:ARGX,NASDAQ:AMGN
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.